Results 141 to 150 of about 165,654 (213)

Clinical implementation of interstitial brachytherapy in early-stage oral cancer in a newly commissioned tertiary cancer center: Challenges and initial experience. [PDF]

open access: yesJ Contemp Brachytherapy
Vadgaonkar RA   +12 more
europepmc   +1 more source

Comparative analysis of target volume coverage and liver exposure in high-dose-rate interstitial brachytherapy and <i>in silico</i> MR LINAC-based stereotactic body radiotherapy plans for colorectal liver metastases. [PDF]

open access: yesClin Transl Radiat Oncol
Mansoorian S   +12 more
europepmc   +1 more source

Catheter removal after interstitial brachytherapy for breast cancer: Feasibility study for task delegation. [PDF]

open access: yesTech Innov Patient Support Radiat Oncol
Pignier M   +8 more
europepmc   +1 more source

Post- versus intra-operative implant for breast cancer interstitial brachytherapy: How to choose? [PDF]

open access: yesJ Contemp Brachytherapy
Gimeno-Morales M   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interstitial Brachytherapy

Neurosurgery Clinics of North America, 1990
In the last several years there has been a renewed interest in interstitial brachytherapy for the treatment of both newly diagnosed and recurrent malignant gliomas and solitary cerebral metastases. A variety of techniques are currently in use for the planning and stereotactic implantation of radioactive isotopes into these tumors.
M W, McDermott   +3 more
openaire   +2 more sources

Interstitial brachytherapy dosimetry update

Radiation Protection Dosimetry, 2006
In March 2004, the American Association of Physicists in Medicine (AAPM) published an update to the AAPM Task Group No. 43 Report (TG-43) which was initially published in 1995. This update was pursued primarily due to the marked increase in permanent implantation of low-energy photon-emitting brachytherapy sources in the United States over the past ...
Mark J, Rivard, Ravinder, Nath
openaire   +2 more sources

Home - About - Disclaimer - Privacy